맘모그래피 시장 규모, 점유율, 동향 및 예측 : 기술별, 제품별, 지역별(2026-2034년)

The global mammography market size was valued at USD 2.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 5.2 Billion by 2034, exhibiting a CAGR of 6.85% from 2026-2034. North America currently dominates the market, holding a market share of 43.9% in 2025. The market is driven by the rising prevalence of breast cancer, increasing awareness about early detection, and government initiatives supporting regular screening programs. Technological advancements, such as three-dimensional (3D) tomosynthesis and artificial intelligence (AI) integration, enhance diagnostic accuracy and fuel adoption. Growing healthcare expenditure, an expanding elderly population, and improved reimbursement policies further bolsters the mammography market share. Additionally, the shift toward minimally invasive diagnostic procedures and increased participation in routine health check-ups contribute significantly to market growth, making mammography an essential tool in cancer care.

One major driver in the mammography market is the rising prevalence of breast cancer worldwide, which has fueled strong demand for early detection and screening solutions. In 2022 alone, approximately 2.3 million new breast cancer cases were diagnosed globally, leading to around 670,000 deaths, highlighting the urgency of timely diagnosis. Breast cancer remains one of the most common cancers among women, prompting healthcare systems to prioritize early detection strategies to improve survival outcomes. Growing awareness campaigns and education programs are encouraging more women to undergo regular screenings. Additionally, governments and healthcare organizations are expanding screening initiatives and reimbursement support, ensuring greater accessibility. This emphasis positions mammography as a critical diagnostic tool, driving consistent mammography market growth.

The U.S. holds a dominant position in the mammography market with a share of 88.20%, supported by its advanced healthcare infrastructure, high breast cancer incidence, and strong focus on early detection. In 2023, approximately 79.8% of women aged 50-74 underwent a mammogram within the past two years, highlighting widespread adoption driven by awareness campaigns, government-supported screening programs, and favorable reimbursement policies. The market benefits from rapid integration of advanced technologies, including 3D digital mammography and AI-powered imaging, which enhance diagnostic accuracy. A large aging female population and rising healthcare spending further fuel demand. Ongoing research, innovation, and clinical trials continue to strengthen breast imaging capabilities, ensuring sustained U.S. leadership in the global mammography market outlook.

MAMMOGRAPHY MARKET TRENDS:

Technological Advancements in Mammography

The adoption of mammography is strongly driven by rapid technological advancements, particularly innovations like 3D digital breast tomosynthesis, full-field digital mammography, and AI-powered imaging analysis. These cutting-edge solutions significantly enhance diagnostic accuracy by providing clearer, more detailed breast images, reducing false positives and unnecessary biopsies. For example, 3D mammography allows radiologists to examine breast tissue layer by layer, improving cancer detection rates, especially in women with dense breast tissue. The integration of artificial intelligence supports radiologists in interpreting results more efficiently, reducing workload while improving detection confidence. Such advancements have boosted patient and physician trust in mammography, leading to higher adoption rates. Moreover, continuous research and development by key industry players ensure that more sophisticated, user-friendly, and cost-effective systems are introduced. This ongoing technological progress not only addresses diagnostic challenges but also accelerates market growth.

Rising Prevalence of Breast Cancer

The increasing global prevalence of breast cancer is a key mammography market trend. Breast cancer remains the most commonly diagnosed cancer among women, with millions of new cases reported annually, making early detection a crucial healthcare priority. Early detection greatly improves outcomes, as five-year survival rates exceed 90% for women diagnosed at earlier stages in screening-positive populations. Mammography continues to serve as the gold standard for breast cancer screening, enabling clinicians to identify tumors at more treatable stages. The growing disease burden has pushed governments, NGOs, and healthcare organizations to intensify awareness campaigns and implement large-scale screening programs worldwide. As more women understand the importance of regular check-ups, adoption of mammography is steadily rising. Additionally, healthcare providers are expanding diagnostic facilities, enhancing accessibility and reinforcing mammography's essential role in reducing global breast cancer mortality rates.

Government Initiatives and Screening Programs

Government initiatives and large-scale screening programs play a vital role in driving the mammography market by ensuring widespread access and affordability. Many countries have introduced national breast cancer screening guidelines, mandating or recommending regular mammograms for women in specific age groups. Public health campaigns emphasize the importance of early detection, encouraging participation in routine screenings. Additionally, government funding, subsidies, and reimbursement policies make mammography more accessible to populations that might otherwise face financial barriers. For instance, healthcare reforms in developed nations like the U.S. and Europe ensure coverage for annual or biennial screenings, significantly boosting demand. In developing regions, international collaborations and NGO-driven programs help establish screening facilities and mobile mammography units to reach underserved areas. These initiatives not only increase awareness and access but also normalize routine screening practices, positioning mammography as a cornerstone of preventive healthcare worldwide.

MAMMOGRAPHY INDUSTRY SEGMENTATION:

Analysis by Technology:

• Breast Tomosynthesis
• CAD
• Digital

According to the mammography market forecast, the digital mammography accounts for the majority of the market share of 64.8%, driven by its ability to deliver high-resolution images, faster results, and enhanced diagnostic precision compared to analog systems. The technology's compatibility with advanced tools such as 3D breast tomosynthesis and AI-driven image analysis further strengthens its clinical value, making it the preferred choice among healthcare providers. Additionally, digital systems streamline workflow efficiency through easy image storage, retrieval, and sharing, reducing delays in diagnosis and treatment. Lower radiation doses, improved patient comfort, and higher detection rates in dense breast tissues contribute to widespread adoption. Supportive government initiatives, reimbursement policies, and the growing demand for advanced screening solutions ensure that digital mammography continues to dominate global market share.

Analysis by Product:

• Film Screen Systems
• Digital Systems
• Analog Systems
• Biopsy Systems
• 3D Systems

Digital systems dominate the mammography market demand with a market share of 59.8%, driven by their superior image quality, faster processing, and improved diagnostic accuracy compared to traditional film-based systems. They enable efficient storage, retrieval, and sharing of images through picture archiving and communication systems (PACS), supporting streamlined workflows and remote consultations. Digital mammography also facilitates advanced technologies like 3D tomosynthesis and AI integration, enhancing early cancer detection and reducing false positives. Hospitals and diagnostic centers prefer these systems due to lower long-term operational costs, reduced radiation exposure, and higher patient throughput. Growing awareness, government support, and reimbursement for digital screenings further accelerate adoption, solidifying digital mammography's position as the standard choice in modern breast imaging practices.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Based on the mammography market analysis, North America is the leading region with a market share of 43.9% driven by its advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, and strong emphasis on early breast cancer detection. The region benefits from widespread awareness campaigns, supportive government policies, and comprehensive reimbursement systems that encourage routine screenings. A significant prevalence of breast cancer, coupled with a growing aging population, fuels continuous demand for mammography services. Additionally, rapid integration of innovations such as 3D tomosynthesis and AI-based imaging strengthens diagnostic capabilities and patient confidence. Strong investments in research, clinical trials, and healthcare digitization further contribute to the region's dominance, positioning North America as a global hub for mammography advancements and early detection initiatives.

KEY REGIONAL TAKEAWAYS:

UNITED STATES MAMMOGRAPHY MARKET ANALYSIS

The United States mammography market is primarily driven by the increasing awareness about the importance of early breast cancer detection. In line with this, continual technological advancements such as digital mammography and 3D imaging, enhancing diagnostic accuracy and precision, are impelling the market. The growing aging population is also contributing to a higher incidence of breast cancer, further fueling market demand. According to the U.S. Census Bureau's Vintage 2024 Population Estimates, the U.S. population aged 65 and older increased by 3.1%, reaching 61.2 million, while the population under age 18 decreased by 0.2%, totaling 73.1 million, from 2023 to 2024. Additionally, supportive government initiatives and the expansion of insurance coverage for preventive care are stimulating market appeal. The rising healthcare expenditure in the U.S., which enables greater investments in advanced imaging systems, is propelling market growth. Furthermore, the heightened prevalence of dense breast tissue, which drives the need for specialized imaging solutions, is fostering market expansion. The rapid integration of artificial intelligence in mammography is improving both diagnostic speed and accuracy. Moreover, the increasing focus on women's health and wellness is creating lucrative opportunities in the market.

EUROPE MAMMOGRAPHY MARKET ANALYSIS

The European market is experiencing growth attributed to the increasing prevalence of breast cancer. Europe, representing 9% of the global population, accounts for 20.3% of cancer deaths and 23.4% of diagnoses. As per the European Cancer Information System, in 2022, 2.74 million new cancer cases were reported, with projections indicating over 3.24 million cases by 2040, highlighting the need for early detection. In accordance with this, the increasing adoption of advanced digital and 3D mammography technologies is improving diagnostic accuracy and market accessibility. The rising focus on preventive healthcare programs is further enhancing screening rates. Similarly, the expansion of public and private insurance coverage is making mammography more affordable, contributing to market growth. The ongoing integration of artificial intelligence in mammography systems, which optimizes diagnostic processes and reduces human error, is strengthening market demand. Furthermore, increasing awareness of women's health and wellness, driving more initiatives aimed at breast cancer prevention, is enhancing market appeal. The aging population in Europe, which faces a higher risk of breast cancer, is also contributing to the market development. Besides this, strategic investments in healthcare infrastructure are accelerating the adoption of these advanced screening technologies.

ASIA PACIFIC MAMMOGRAPHY MARKET ANALYSIS

The mammography market in the Asia Pacific is largely propelled by the rising prevalence of breast cancer, which is increasing the demand for early detection solutions. According to NCBI, breast cancer is a major health issue in Asia, with an estimated 985.4 thousand new cases and 315.1 thousand deaths reported in 2022. The age-standardized incidence and mortality rates are 34.3 and 10.5 per 100,000, respectively, highlighting the critical need for effective screening and early detection. Additionally, continuous improvements in healthcare infrastructure are enhancing access to advanced diagnostic technologies like digital mammography. The strong government initiatives and public health campaigns are further encouraging regular breast screenings. Furthermore, the growing awareness among women about breast cancer prevention is contributing to the increased adoption of mammography services. The increasing availability and affordability of advanced imaging technologies are augmenting market growth. Moreover, the expansion of private healthcare facilities offering specialized diagnostic services is improving access to high-quality mammography, thereby impacting the market trends.

LATIN AMERICA MAMMOGRAPHY MARKET ANALYSIS

In Latin America, the market is expanding due to increasing healthcare investments aimed at improving cancer detection services. As such, in January 2025, Mamotest secured a USD 1.5 Million investment from Philips Foundation to scale AI-driven breast cancer care. The funding will enhance diagnostics, improve patient outcomes, and expand Mamotest's reach in Latin America and Europe, benefiting underserved populations. Similarly, the rising awareness campaigns focused on breast cancer prevention are encouraging women to undergo regular screenings. The expansion of healthcare insurance coverage is increasing access to mammography, particularly in underserved areas. Moreover, the growing adoption of advanced imaging technologies, such as digital and 3D mammography, is improving diagnostic accuracy and fueling demand for more effective screening solutions, providing an impetus to the market.

MIDDLE EAST AND AFRICA MAMMOGRAPHY MARKET ANALYSIS

The mammography market in the Middle East and Africa is influenced by the rising healthcare investments in both public and private sectors, enhancing access to advanced diagnostic tools. Similarly, favorable government initiatives promoting women's health and preventive care are further supporting market demand. The heightened awareness of breast cancer prevention, leading to higher screening rates, is fostering market expansion. In Saudi Arabia, breast cancer is the most common cancer among women. A study in Arar City showed 84.2% awareness of breast self-examination (BSE), with 80% of participants having good knowledge of BSE and mammography. Furthermore, the growing adoption of mobile health solutions and telemedicine is expanding access to mammography services, especially in remote areas.

COMPETITIVE LANDSCAPE:

The competitive landscape is characterized by intense innovation, technological advancement, and strategic expansion. Market players focus heavily on developing advanced imaging solutions, such as 3D tomosynthesis, digital breast imaging, and AI-powered diagnostic tools, to improve accuracy and efficiency. Competition is fueled by the rising demand for early detection technologies, pushing companies to enhance product portfolios and invest in research and development (R&D). Additionally, partnerships with healthcare providers, regulatory approvals, and global distribution networks are crucial strategies for gaining market share. The landscape also reflects a balance between established manufacturers offering premium solutions and emerging players providing cost-effective alternatives, creating a dynamic environment that drives continuous technological progress and accessibility worldwide.

The report provides a comprehensive analysis of the competitive landscape in the mammography market with detailed profiles of all major companies.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the mammography market?

2. What is the future outlook of mammography market?

3. What are the key factors driving the mammography market?

4. Which region accounts for the largest mammography market share?

5. Which are the leading companies in the global mammography market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Mammography Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Technology

• 6.1 Breast Tomosynthesis
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 CAD
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Digital
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Product

• 7.1 Film Screen Systems
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Digital Systems
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Analog Systems
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Biopsy Systems
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 3D Systems
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Analogic Corporation
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 SWOT Analysis
  • 13.3.2 Carestream Health (Onex Corporation)
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Fujifilm Holdings Corporation
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 General Electric Company
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Hologic Inc.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 Konica Minolta Inc.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Metaltronica S.p.A.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 Mindray Medical International Limited
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 Koninklijke Philips N.V.
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Planmed Oy (Planmeca Oy)
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
  • 13.3.11 Siemens AG
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 Financials
    • 13.3.11.4 SWOT Analysis